On 31 December 2025, the European Banking Authority (EBA) will transfer its anti-money laundering mandate to the Anti-Money Laundering ...

Get the latest on Curis, Inc.’s Q3 2025 earnings, clinical trial milestones, and investment outlook in rare lymphoma and CLL.

M2T-CD33 (LTI-214) has received FDA orphan drug designation, offering incentives like tax credits and market exclusivity for AML treatment. The treatment targets CD33, a glycoprotein present in 90% of ...

Coinbase has been fined €21.5 million by the Central Bank of Ireland after failing to monitor suspicious crypto transactions.

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to M2T-CD33 (LTI-214) for the treatment of ...

ArcelorMittal Liberia (AML), in partnership with the Government of Liberia, has announced the launch of the 10th batch of its ...

Leukogene Therapeutics Inc.’s lead product candidate LTI-214 (M2T-CD33) has been awarded orphan drug designation by the FDA for the treatment of acute myeloid leukemia (AML).

Panelists discuss how IDH inhibitors, particularly ivosidenib combined with azacitidine, represent potentially the greatest ...

Two Presentations at ASH 2025 to highlight preclinical data and clinical development plans for GB3226, a novel dual ENL-YEATS and FLT3 inhibitor ...

Any business that has not updated its AML documentation and processes since September is likely to be non-compliant, says COO, John Reynolds.

Nearly a third of law firms checked by the SRA for their approach to anti-money laundering in the past year were ...

The Solicitors Regulatory Authority has recently published its annual AML compliance report. The SRA carried out 864 'proactive engagements', including ...